Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41463
metadata.artigo.dc.title: | COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? |
metadata.artigo.dc.creator: | Colafrancesco, Serena Alessandri, Cristiano Conti, Fabrizio Priori, Roberta |
metadata.artigo.dc.subject: | COVID-19 Cytokine storm Inflammation Ferritin |
metadata.artigo.dc.publisher: | Elsevier |
metadata.artigo.dc.date.issued: | Jul-2020 |
metadata.artigo.dc.identifier.citation: | COLAFRANCESCO, S. et al. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmunity Reviews, [S.l.], v. 19, n. 7, July 2020. |
metadata.artigo.dc.description.abstract: | The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndromes” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and “hyperferritinemic syndromes” which would allow considering severe COVID-19 as a fifth member of this spectrum of inflammatory conditions. |
metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S156899722030135X http://repositorio.ufla.br/jspui/handle/1/41463 |
metadata.artigo.dc.language: | en_US |
Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.